These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 28350758
21. Effect of raloxifene on sexual function in postmenopausal women. Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A. Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773 [Abstract] [Full Text] [Related]
22. Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial. Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C. Menopause; 2020 May; 27(5):526-534. PubMed ID: 32049923 [Abstract] [Full Text] [Related]
23. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial. Zohrabi I, Abedi P, Ansari S, Maraghi E, Shakiba Maram N, Houshmand G. BMC Womens Health; 2020 May 19; 20(1):108. PubMed ID: 32429977 [Abstract] [Full Text] [Related]
24. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL. Menopause; 2009 May 19; 16(5):978-83. PubMed ID: 19390463 [Abstract] [Full Text] [Related]
25. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule? Murina F, Graziottin A, Felice R, Di Francesco S. Eur J Obstet Gynecol Reprod Biol; 2016 Dec 19; 207():121-124. PubMed ID: 27838536 [Abstract] [Full Text] [Related]
26. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Barentsen R, van de Weijer PH, Schram JH. Eur J Obstet Gynecol Reprod Biol; 1997 Jan 19; 71(1):73-80. PubMed ID: 9031963 [Abstract] [Full Text] [Related]
27. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience]. Oliva FA, Saltarelli E, D'Antonio GD, Mazzatenta E. Minerva Ginecol; 1991 Dec 19; 43(12):605-7. PubMed ID: 1819780 [Abstract] [Full Text] [Related]
28. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial. Lima SM, Bernardo BF, Yamada SS, Reis BF, da Silva GM, Galvão MA. Maturitas; 2014 Jul 19; 78(3):205-11. PubMed ID: 24856055 [Abstract] [Full Text] [Related]
29. Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study. Fernandes T, Pedro AO, Baccaro LF, Costa-Paiva LH. Menopause; 2018 Jun 19; 25(6):641-647. PubMed ID: 29462095 [Abstract] [Full Text] [Related]
30. The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study. Weber MA, Lim V, Oryszczyn J, Te West N, Souget J, Jeffery S, Roovers JP, Moore KH. Gynecol Obstet Invest; 2017 Jun 19; 82(1):15-21. PubMed ID: 26990867 [Abstract] [Full Text] [Related]
31. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Dugal R, Hesla K, Sørdal T, Aase KH, Lilleeidet O, Wickstrøm E. Acta Obstet Gynecol Scand; 2000 Apr 19; 79(4):293-7. PubMed ID: 10746845 [Abstract] [Full Text] [Related]
32. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Vicariotto F, DE Seta F, Faoro V, Raichi M. Minerva Ginecol; 2017 Aug 19; 69(4):342-349. PubMed ID: 28608667 [Abstract] [Full Text] [Related]
33. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. Donders G, Bellen G, Neven P, Grob P, Prasauskas V, Buchholz S, Ortmann O. Eur J Clin Microbiol Infect Dis; 2015 Oct 19; 34(10):2023-8. PubMed ID: 26223323 [Abstract] [Full Text] [Related]
34. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors. Carter J, Baser RE, Goldfrank DJ, Seidel B, Milli L, Stabile C, Canty J, Saban S, Goldfarb S, Dickler MN, Gardner GJ, Jewell EL, Sonoda Y, Kollmeier MA, Alektiar KM. Support Care Cancer; 2021 Jan 19; 29(1):311-322. PubMed ID: 32358778 [Abstract] [Full Text] [Related]
35. [Local estrogen therapy--clinical implications--2012 update]. Kokot-Kierepa M, Bartuzi A, Kulik-Rechberger B, Rechberger T. Ginekol Pol; 2012 Oct 19; 83(10):772-7. PubMed ID: 23383564 [Abstract] [Full Text] [Related]
36. Effects of preoperative vaginal estrogen therapy for the incidence of mesh complication after pelvic organ prolapse surgery in postmenopausal women: is it helpful or a myth? A 1-year randomized controlled trial. Sun Z, Zhu L, Xu T, Shi X, Lang J. Menopause; 2016 Jul 19; 23(7):740-8. PubMed ID: 27163518 [Abstract] [Full Text] [Related]
37. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy. Bachmann G, Bobula J, Mirkin S. Climacteric; 2010 Apr 19; 13(2):132-40. PubMed ID: 19863455 [Abstract] [Full Text] [Related]
38. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E. Menopause; 2004 Apr 19; 11(1):49-56. PubMed ID: 14716182 [Abstract] [Full Text] [Related]